Tony Butler
Stock Analyst at Rodman & Renshaw
(0.76)
# 3,982
Out of 5,014 analysts
105
Total ratings
32.35%
Success rate
-13.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $16.08 | +55.47% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.58 | +326.36% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.79 | +905.59% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.08 | +621.15% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.69 | +1,066.18% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.60 | +2,580.07% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.22 | +4,443.39% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.61 | +521.12% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $74.92 | +0.11% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $94.58 | -62.99% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $0.75 | +7,888.28% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.92 | +577.08% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $8.87 | +463.70% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.51 | +893.38% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.02 | +2,350.98% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.83 | +291.64% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $9.93 | +0.70% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.38 | +402.96% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $4.25 | +3,805.88% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.63 | +1,195.90% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.33 | +10,200.43% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.60 | +900.00% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $4.54 | +7,829.52% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $5.52 | -63.77% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.30 | +354.55% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.05 | +852.38% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.07 | +268.55% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $25.46 | +332.05% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $6.84 | +13,936.93% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $16.08
Upside: +55.47%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.58
Upside: +326.36%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.79
Upside: +905.59%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.08
Upside: +621.15%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.69
Upside: +1,066.18%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.60
Upside: +2,580.07%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.22
Upside: +4,443.39%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.61
Upside: +521.12%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $74.92
Upside: +0.11%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $94.58
Upside: -62.99%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.75
Upside: +7,888.28%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.92
Upside: +577.08%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $8.87
Upside: +463.70%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.51
Upside: +893.38%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $1.02
Upside: +2,350.98%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $3.83
Upside: +291.64%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $9.93
Upside: +0.70%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $3.38
Upside: +402.96%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $4.25
Upside: +3,805.88%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $4.63
Upside: +1,195.90%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.33
Upside: +10,200.43%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.60
Upside: +900.00%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $4.54
Upside: +7,829.52%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $5.52
Upside: -63.77%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.30
Upside: +354.55%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.05
Upside: +852.38%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $4.07
Upside: +268.55%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $25.46
Upside: +332.05%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $6.84
Upside: +13,936.93%